A Vertically Integrated Industry Leader
Our vertically integrated business allows us to adequately meet your requirements and aides in mitigating your supply chain risk.
WHAT WE DO
Our ~30,000 employees are scientists, researchers, communicators, manufacturing specialists and regulatory experts located around the globe. We come up with new approaches to addressing today’s health issues—from life-threatening illness to chronic conditions.
We target specific difficult-to-cure diseases where we can leverage our core R&D expertise to advance science. We’re constantly working to create solutions that go beyond treating the illness to have a positive impact on patients’ lives, on societies—and on science itself.
We target specific difficult-to-cure diseases where we can leverage our core R&D expertise to advance science. We’re constantly working to create solutions that go beyond treating the illness to have a positive impact on patients’ lives, on societies—and on science itself.
FOR 30+ YEARS, OUR MISSION HAS BEEN TO USE THE POWER OF SCIENCE TO BRING NEW MEDICINES TO PATIENTS... OVER AND OVER AGAIN
- Head of Research & Development
OUR HISTORY
Scientist, philanthropist and entrepreneur, Dr. K Anji Reddy's passion for drug discovery and his pioneering contributions to making medicines affordable are legendary.
Born in Tadepalli in the Guntur district of Andhra Pradesh, India, in a well to do farming family, he grew up watching his father make herbal pills that he distributed free. Little did he realize the prophetic significance of what he saw.
Born in Tadepalli in the Guntur district of Andhra Pradesh, India, in a well to do farming family, he grew up watching his father make herbal pills that he distributed free. Little did he realize the prophetic significance of what he saw.
The seeds of his lifelong passion for pharmaceuticals were sown when he was pursuing a BSc Tech degree at the University Department of Chemical Technology, Mumbai. He went on to secure a Doctorate in Chemical Engineering, subsequently, from the National Chemical Laboratory, Pune. He then worked for six years at the state owned Indian Drugs and Pharmaceuticals Limited, where his entrepreneurial ambitions were fired. In 1973, he left IDPL and over the next ten years was part of the founding team of two bulk drug manufacturing ventures.
METROCHEM BY THE NUMBERS
$
0
+
Recorded Revenue 2019
#
0
In Indian Antiulceratives APIs Market
0
+
Team of R&D Scientists
0
KL
Reactors' Volume
0
+
Tons of API Annual Production
0
+
Products in High Growth Therapeutic Categories
0
+
Reactors (Ranging from 5L to 15KL)
0
+
Our Current Workforce
0
+
Countries Served Across the Globe
ACCREDITATIONS
Recognitions/Awards:
Metrochem API has been Awarded by All India Manufacturer's Organization (AIMO) in 2006 for the best performance Award 2006, received from the honorable Governor of A.P., India.
Financials:
In a short span of 15 years, we have recorded from USD 0 to above USD 100 million.
Patents:
Metrochem API has been Awarded by All India Manufacturer's Organization (AIMO) in 2006 for the best performance Award 2006, received from the honorable Governor of A.P., India.
Financials:
In a short span of 15 years, we have recorded from USD 0 to above USD 100 million.
Patents:
- Process Patent granted for Preparing Prazole Precursors.
- Process Patent granted for Preparing 4-Chloro Pyridine Derivatives.
- Process Patent granted for Preparing Prazole Compounds.
- Process Patent granted for Preparing Esomeprazole Magnesium Salts.
